Oncologie- CHU Limoges
Limoges, 87000, France
NCT Number: NCT02013921
Many studies have demonstrated the beneficial effects of Adapted Physical Activity (APA) in different cancer types.
It therefore seems necessary to assess spontaneous Physical Activity in order to integrate it to the overall calculation of physical activity in clinical practice.
To assess the AP, two types of methods are validated : the subjective method using a questionnaries and objective method using a pedometer , accelerometer or measures calorimetry .
Subjective method shows , good acceptability by patients and low cost but can sometimes lead to poor estimation of the level of activity.
Objective methods obviously increase the accuracy of assessments but are more difficult to use for epidemiological studies , less accepted by the patient and more expensive.
In this study the investigators will measure the spontaneous Daily Physical Activity by both methods andd evaluate the correclation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Limoges, 87000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: Month 3
Physical activity is measured by means of an Actigraph. Patients will measure their daily physical activity , three times during one week espaced by 1 month.
University Hospital, Limoges
Other
Evaluation du Niveau d'activité Physique Quotidien, Chez Des Patientes Porteuses d'un Cancer du Sein en période Post thérapeutique
Acronym: APQ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05613699
Alzheimer Disease, Behavior
Heidelberg, Baden-Wurttemberg, Germany
View Trial DetailsNCT04083300
Behavior, Cancer
Bergen, Norway
View Trial DetailsNCT03120819
Behavior, Cancer
Portland, Oregon, United States
View Trial DetailsNCT04533165
Behavior, Cancer
Aurora, Colorado, United States
View Trial Details